Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10941395 Method for gene editing

Patent 10941395 was granted and assigned to Massachusetts Institute of Technology on March, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Massachusetts Institute of Technology
Massachusetts Institute of Technology
0
Date Filed
July 6, 2018
0
Date of Patent
March 9, 2021
0
Patent Applicant
Massachusetts Institute of Technology
Massachusetts Institute of Technology
0
Patent Application Number
16029273
0
Patent Citations
‌
US Patent 10047355 Delivery systems and kits for gene editing
0
Patent Citations Received
‌
US Patent 11446394 Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery
‌
US Patent 12123032 CRISPR enzyme mutations reducing off-target effects
0
‌
US Patent 11701434 Tertiary amino lipidated cationic peptides for nucleic acid delivery
0
Patent Inventor Names
Tyler E. Jacks
0
Daniel G. Anderson
0
Hao Yin
0
Joseph R. Dorkin
0
Wen Xue
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10941395
0
Patent Primary Examiner
‌
Scott Long
0

Find more entities like US Patent 10941395 Method for gene editing

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.